Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04083742 · ClinicalTrials.gov registry record
The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 59
- Enrollment target
NCT04083742: Completed study, sponsored by Heidelberg Engineering.
NCT04083742 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04083742 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment metrics with the ANTERION
Primary Outcome
Reproducibility and repeatability of Spur to Spur distance parameter \[mm\] of ANTERION and the reference device
Interventions
- DEVICE ANTERION
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2019-08-22 |
| Est. Completion | 2023-12-31 |
What the finished NCT04083742 record still lists
NCT04083742 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ANTERION is the first listed.
NCT04083742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04083742 about?
NCT04083742 is a clinical study titled "The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study". This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment metrics with the ANTERION
What is the current status of trial NCT04083742?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2019-08-22. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04083742?
The interventions under investigation include: ANTERION (DEVICE).
Who is sponsoring clinical trial NCT04083742?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI